Author: John Murphy, CEO COVID 19 Long-haul Foundation Abstract The SARS-CoV-2 spike glycoprotein, central to viral entry and the target of mRNA vaccine platforms, has emerged as a persistent antigen…[...]
Read More
Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by persistent symptoms affecting multiple organ systems. Among its most compelling…[...]
Read More
Andrea Polli, Lode Godderis, Dries S. Martens, et. al., , BMC Medicine volume 23, Article number: 60 (2025) Cite this article Abstract Background Long-COVID is defined as the persistency or development of new symptoms 3 months after the initial SARS-CoV-2…[...]
Read More
Reactive arthritis can develop after COVID-19 due to immune system activation. The virus triggers inflammation that may mistakenly target joint tissues, even if joints weren’t affected during the acute illness2.…[...]
Read More
John Murphy, President The COVID-19 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines have transformed infectious disease prevention, particularly during the COVID-19 pandemic. While their safety profile is robust, emerging evidence…[...]
Read More
Faiza Humayun Khan • Ahsan Ayaz • Tamer Zahdeh, DOI: 10.7759/cureus.84833 Abstract Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma that can be associated with autoimmune hemolytic anemia (AIHA), including the rare cold…[...]
Read More
Researchers Xiaoqin Wei, PhD, and Jie Sun, PhD, have made a COVID-19 discovery that could open the door to new treatments for the lingering effects of not just COVID but…[...]
Read More
Association of American Physicians and Surgeons TUCSON, Ariz., June 02, 2025 (GLOBE NEWSWIRE) -- Endocrine effects that may result from vaccination are deceptively subtle at their onset. Hence, robust and…[...]
Read More
John Murphy, CEO & President, COVID-19 Long-haul Foundation Abstract SARS-CoV-2 provokes a uniquely heterogeneous and dynamic immune response that ranges from efficient viral control to fulminant hyperinflammation and prolonged immune…[...]
Read More
By Josh Christenson WASHINGTON — Officials at the Centers for Disease Control and Prevention (CDC) discussed how to downplay concerns about COVID-19 vaccine efficacy and avoid “too precise” comparisons between the benefits of…[...]
Read More